Evidence map›Paper›PMID 10677300›Full record

ArticleAmerican journal of human genetics2000

Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.

R D Hundscheid, E A Sistermans, C M Thomas, D D Braat, H Straatman, L A Kiemeney, B A Oostra, A P Smits

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Ovarian aging and premature ovarian failure.Journal of the Turkish German Gynecological Association · 2014
    Review
  6. Pathogenesis and causes of premature ovarian failure: an update.International journal of fertility & sterility · 2011
    Review
  7. FMR1: a gene with three faces.Biochimica et biophysica acta · 2009
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

R D HundscheidDepartment of Human Genetics, University Hospital Nijmegen, 6500 HB Nijmegen, The Netherlands.
E A Sistermans
C M Thomas
D D Braat
H Straatman
L A Kiemeney
B A Oostra
A P Smits
Radboud University Nijmegen · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile X premutations are considered to be a risk factor for premature ovarian failure (POF), which is usually defined as menopause at age <40 years. Since premutations may be inherited from either the mother or the father, we evaluated the influence of the inheritance pattern on the duration of reproductive life in female carriers. The occurrence of POF and age at menopause in women with a paternally inherited fragile X premutation (PIP) were compared to those in women with a maternally inherited fragile X premutation (MIP). We identified 148 women in whom the parental origin of the premutation could be determined. In 109 of these women we were able to establish whether POF had occurred: 82 women had a PIP, and 27 had a MIP. Twenty-three of the women (28%) with a PIP had POF, versus only 1 (3.7%) with a MIP (two -tailed Fisher's exact test; P=. 007). Kaplan-Meier analysis of all 148 premutations showed that the age at menopause was significantly lower in the women with a PIP than in the woman with a MIP (Breslow test in Kaplan-Meier analysis; P=.003). Our data strongly suggest that, when POF occurs in fragile X premutation carriers, a considerable proportion of the premutations are inherited paternally (parent-of-origin effect). We hypothesize that this may be owing to a paternal genomic imprinting effect.

Indexed as

FathersRNA-Binding ProteinsAdultAge of OnsetFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGenetic Predisposition to DiseaseGenomic ImprintingHeterozygoteHumansMaleMenopauseMenstrual CycleMiddle AgedModels, GeneticFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Nerve Tissue ProteinsRNA-Binding Proteins

Identifiers

PMID10677300
PMCPMC1288093
OpenAlexW2067324242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.